OTC Stock News

[PennyStock Alert]

Silicon Valley biotech, $ARYC, Arrayit Corporation, is an extremely undervalued stock that is currently trading just under a penny per share
 
ARYC is awaiting the completion of the extensive audit covering almost 4 years of financials (2014, 2015, 2016, and Q1, Q2 and Q3 of 2017). We are expecting the 2014/15 audit financials out by end of November, with the 2016 and 2017 release to follow soon, thereafter.
 
Upon the final completion of the audited financials and installation of the new state of the art equipment that will double manufacturing capacity, there is no reason that ARYC should not be trading in the $.25 - $1 range per share.
 
We expect it to reach this level within the next year. This is once in a lifetime opportunity and ARYC is a stock to accumulate for generational wealth. Buying shares at a penny per share and holding, will create immense wealth.  There are no promotions, no paid pumping, no dilution. ARYC is a real, state of the art company, that is working its way to  Nasdaq and is a potential buyout candidate from Johnson & Johnson, Illumina, or its next door neighbor, Apple. We highly recommend adding shares while you can, before it's too late.
 
A few of the many highlights of ARYC below.

Sales in excess of $20,000 almost every day
 
? Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
? ARYC also owns 40 million shares of AVDX.
? Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold
? Arrayit manufacturing team completes 800 whole blood card production run for the United States Department of Defense (link: https://www.defense.gov)
? Arrayit reports Parkinson's Disease Test PDx™ partnering opportunity with top physician in Molecular Medicine India (link: http://nimhans.ac.in) nimhans.ac.in  
? Arrayit reports $2,500,000 microarray services inquiry from United States Department Veteran Affairs Washington DC https://www.va.gov
? Arrayit and United States Department of Agriculture USDA scientists publish Food Safety Test in top science journal http://www.mdpi.com/1424-8220/17/9/2157/htm …
? Arrayit reports microarray technology sale to EU life sciences leader European Biotech Network Dolembreux Belgium http://euro-bio-net.net/network/
? Arrayit president Dr Mark Schena's mentor Dr Ronald Davis named as one of Today's Greatest Inventors in The Atlantic https://www.theatlantic.com/magazine/archive/2013/11/the-inventors/309534/ …
? Arrayit reports $350,000 microarray services inquiry from leading Veterans Administration Health Care Palo Alto CA paloalto.va.gov
? Arrayit microarray services team commences $88,000 overnight manufacturing run for a major protein research account http://arrayit.com/Services/services.html …
? Arrayit microarray services team completes $550,000 manufacturing run for a major biomedical research customer http://arrayit.com/Services/services.html …
? Arrayit services team currently adding new state of the art equipment that will doubles manufacturing capacity to meet increasing demand for their proprietary microarray tech.
 
You can do further research by using the site below
 
http://www.arrayit.com/
http://

Link to their products:
http://www.arrayit.com/Products/products.html

arrayit.blogspot.com/

http://arrayit.com/

Microarray_Investor/Arrayit_Technology/

arrayit_technology.html

https://twitter.com/arrayit
https://www.facebook.com/Arrayit/
http://www.avantdiagnostics.com/

 
You can follow our group for further questions and upcoming new stock picks at the sites below.
 
https://www.facebook.com/pennytradersclub/
 
https://twitter.com/PSTClub1
 
PTC and its club members are NOT compensated for any current or past mentioned stocks  in any way. Investing in Pink and OTC sub penny stocks have a high risk factor for tremendous gains and losses and may cause you to lose some or all of your investment.
Never invest in Penny Stocks with money you cannot afford to lose. Please invest wisely after performing your own Due Diligence.
- [ ]